MRNA:Moderna Inc Snapshot | Charting | News | Options
$28.49 NASDAQ 7:12p ET
September 24 '25 		Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK ACCESSWIRE
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
     ACCESSWIRE

    The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population

    The facility marks a cornerstone of Moderna's ten-year strategic partnership with the UK Government, designed to strengthen health resilience and drive economic growth

    Full Story →

    Headline News
    Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
    7:12a ET September 23 '25 ACCESSWIRE
    Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
    3:22p ET September 19 '25 ACCESSWIRE
    Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
    6:12a ET September 16 '25 ACCESSWIRE
    More News →
    Day  0.42%Week  16.3%Month  18.5%More Charting →
    October 3 '25. Markets Closed.
    Last $28.49
    Day change   0.42%$0.12
    Open $28.66
    Gap at open $0.29
    Previous close $28.37
    Trading volume 8,039,312
    10 Day avg vol. 10,962,712
    Shares out. 389.1Mil
    Market cap. $11.1Bil
    Trading activity Below Avg.
    Previous data from yesterday, October 2 '25.

    Historical Price Performance
    3 month   6.56% 
    6 month   13.46% 
    1 year   53.35% 
    2 year   72.67% 

    Earnings
    Previous 12m -$7.50
    Next 12m Estimate -$9.73
    P/E ratio --
    Revenue 3,078Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.